The encoded protein plays an important role in the innate immune response against DNA and RNA viruses. It is an important transcriptional regulator of type I interferon (IFN)-dependent immune responses and plays a crucial role in the innate immune response against DNA and RNA viruses. Furthermore, the interferon regulatory factor 7 encoded by this gene regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters. It can efficiently activate both IFN-beta (IFNB) and IFN-alpha (IFNA) genes and mediate their induction via both the virus-activated, MyD88-independent pathway and the TLR-activated, MyD88-dependent pathway.
The protein is required in both the early and late phases of IFN gene induction. It exists in an inactive form in the cytoplasm of uninfected cells and is phosphorylated by the kinases IKBKE and TBK1 after viral infection, double-stranded RNA (dsRNA) or Toll-like receptor (TLR) signaling. This results in a conformational change that leads to its dimerization and nuclear localization, where it can activate transcription of type I IFN and ISG genes together with other coactivators. Can activate various gene expression programs in macrophages and regulate the anti-tumor properties of primary macrophages.
Diseases associated with IRF7 include:
- autosomal recessive immunodeficiency 39 (OMIM: 616345) and predisposition to severe viral infections due to IRF7 protein deficiency.